One of the most promising biotechs to emerge from the UK, METRC-supported QuantuMDx, is launching its first major recruitment drive in the N8 region, creating a range of exciting job opportunities for up and coming scientists to further develop its groundbreaking technologies.
METRC, the N8 centre for nanotechnology, science and engineering research, has provided QuantuMDx with access to world leading research in the N8 universities. This led to the company relocating to Newcastle at the end of last year. The high growth company, which is developing the world’s first handheld, clinical DNA diagnostic and sequencing device, has begun recruiting for a range of scientific positions to further develop its groundbreaking technologies. Nine scientists are being sought, including six PhD level candidates, with expertise in molecular biology, chemistry and engineering.
The focus of work for the new recruits will be to help develop and commercialise the company’s first product called Q-POC™ (QuantuMDx point of care), a very low cost handheld diagnostic device much like a smartphone. The company aims to get its technology into the hands of doctors, nurses and pharmacists to enable patients to receive an accurate diagnosis and treatment for their illnesses (such as cancer, cardiac and infectious diseases) within a single visit to their health professional, without the anxiety of waiting days, weeks or even months for test results.
For further information on each post, please visit QuantuMDx’s website